A Molecular Map for Neurodegeneration
- 21 July 2000
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 289 (5478) , 409-411
- https://doi.org/10.1126/science.289.5478.409
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- In vivo detection of amyloid plaques in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2000
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- A Randomized Controlled Trial Comparing Pramipexole with Levodopa in Early Parkinson's Disease: Design and Methods of the CALM-PD StudyClinical Neuropharmacology, 2000
- An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s diseaseBrain, 1996
- Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein ENew England Journal of Medicine, 1996
- [sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseNeurology, 1996
- Clinical and [18F] dopa PET findings in early Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's diseaseNeuroscience Letters, 1995
- Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.Proceedings of the National Academy of Sciences, 1993
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973